Products

Deflazacort API Manufacturing Excellence

Micro Orgo Chem (MOC) is a premier manufacturer of high-purity Deflazacort API. As a critical glucocorticoid used in the management of Duchenne Muscular Dystrophy (DMD), our Deflazacort is synthesized to ensure maximum muscle strength retention and improved quality of life for pediatric and adult patients.

Produced in our GMP certified facility, our Deflazacort meets the highest international standards (IP/USP/IHS). We offer specialized Micronized Grades with a controlled particle size (D90 < 10 microns) for optimal suspension stability and Injectable Grades for advanced clinical R&D.

Duchenne Muscular Dystrophy Products Portfolio

ACTIVE PHARMACEUTICAL INGREDIENTS PRODUCTS
PRODUCT NAME PHARMACOPEIAL GRADE DMF STATUS (Open Part) DMF STATUS (Close Part) CAS NUMBER
DEFLAZACORT IHS 14484-47-0

Strategic Partner for Orphan Drug Development

Developing therapies for DMD requires an API with zero lead-time disruption and absolute batch-to-batch consistency. At Micro Orgo Chem, we utilize proprietary synthesis pathways that result in an ultra-pure Deflazacort profile with minimized bone demineralization potential. Our Micronization technology ensures that our API is ideally suited for oral suspension formulations, providing uniform dosage accuracy which is vital for pediatric patients.

Our Clients

For bulk procurement or technical specifications, contact our sales team.